Drug Shortage Report for ERWINASE
| Report ID | 117975 |
| Drug Identification Number | 02237815 |
| Brand name | ERWINASE |
| Common or Proper name | Erwinia L-asparaginase |
| Company Name | JAZZ PHARMACEUTICALS FRANCE SAS |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | ASPARAGINASE |
| Strength(s) | 10000UNIT |
| Dosage form(s) | POWDER FOR SOLUTION |
| Route of administration | INTRAMUSCULAR INTRAVENOUS SUBCUTANEOUS INTRAMUSCULAR INTRAVENOUS SUBCUTANEOUS |
| Packaging size | 5 vials per box |
| ATC code | L01XX |
| ATC description | OTHER ANTINEOPLASTIC AGENTS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2020-06-16 |
| Estimated end date | Unknown |
| Actual end date | 2021-03-10 |
| Shortage status | Resolved |
| Updated date | 2021-03-16 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 84 QUAI CHARLES DE GAULLE CITY ONE LYON, AUVERGNE-RHONE-ALPES FRANCE 69006 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2021-03-16 | French | Compare |
| v5 | 2021-03-16 | English | Compare |
| v4 | 2020-06-17 | English | Compare |
| v3 | 2020-06-16 | French | Compare |
| v2 | 2020-06-16 | French | Compare |
| v1 | 2020-06-16 | English | Compare |
Showing 1 to 6 of 6